title: Antituberculous therapy and acute liver function.
authors.forename: S J
authors.initials: SJ
authors.lastname: Bourke
authors.forename: J
authors.initials: J
authors.lastname: White
authors.forename: S C
authors.initials: SC
authors.lastname: Stenton
authors.forename: D J
authors.initials: DJ
authors.lastname: Hendrick
mesh_terms: D000328:Adult; D000995:Antitubercular Agents / Q000008:administration & dosage / Q000009:adverse effects*; D004359:Drug Therapy, Combination; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D007538:Isoniazid / Q000008:administration & dosage / Q000009:adverse effects; D008111:Liver Function Tests; D011718:Pyrazinamide / Q000008:administration & dosage / Q000009:adverse effects; D012293:Rifampin / Q000008:administration & dosage / Q000009:adverse effects; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*
chemical_list: D000995:Antitubercular Agents; D011718:Pyrazinamide; D007538:Isoniazid; D012293:Rifampin